|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2000-7-6
|
|
pubmed:abstractText |
To assess the clinical relevance of minimal residual disease (MRD) in patients with multiple myeloma (MM), 50 patients were monitored while they were in complete clinical remission (CCR) after autologous or allogeneic stem-cell transplantation.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:AmabiliAA,
pubmed-author:BandiniGG,
pubmed-author:CaròDD,
pubmed-author:GozzettiAA,
pubmed-author:LemoliR MRM,
pubmed-author:MartinelliGG,
pubmed-author:MottaM RMR,
pubmed-author:OttavianiEE,
pubmed-author:RonconiSS,
pubmed-author:TerragnaCC,
pubmed-author:TestoniNN,
pubmed-author:TosiPP,
pubmed-author:TuraSS,
pubmed-author:VianelliNN,
pubmed-author:ZamagniEE,
pubmed-author:de VivoAA
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2273-81
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10829048-Adult,
pubmed-meshheading:10829048-DNA, Neoplasm,
pubmed-meshheading:10829048-Female,
pubmed-meshheading:10829048-Gene Rearrangement,
pubmed-meshheading:10829048-Genetic Markers,
pubmed-meshheading:10829048-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:10829048-Humans,
pubmed-meshheading:10829048-Male,
pubmed-meshheading:10829048-Middle Aged,
pubmed-meshheading:10829048-Multiple Myeloma,
pubmed-meshheading:10829048-Neoplasm, Residual,
pubmed-meshheading:10829048-Polymerase Chain Reaction,
pubmed-meshheading:10829048-Remission Induction,
pubmed-meshheading:10829048-Retrospective Studies,
pubmed-meshheading:10829048-Survival Analysis,
pubmed-meshheading:10829048-Transplantation, Autologous,
pubmed-meshheading:10829048-Transplantation, Homologous,
pubmed-meshheading:10829048-Tumor Markers, Biological
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myeloma.
|
|
pubmed:affiliation |
Institute of Hematology and Medical Oncology "Seràgnoli," University of Bologna, Italy. gmartino@kaiser.alma.unibo.it
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
